Daily Market Reports | 12:24 PM
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ADT ASX AV1 AX1 (2) BRE BRG CLG COH CUP LGL RXL RXR STN SVL TPG WIA (2)
ADT ADRIATIC METALS PLC
Gold & Silver - Overnight Price: $5.00
Canaccord Genuity rates ((ADT)) as Hold (3) -
Canaccord Genuity reports Canadian gold miner Dundee Precious Metals will acquire Adriatic Metals via a cash and scrip deal valuing the company at $1.92bn, or $5.56 per share.
Adriatics board and major shareholders Helikon Investments and L1 Capital intend to support the transaction.
While the headline premium to Adriatics last close is 11%, the implied offer is 51% above the share price before confirmation of takeover talks, which Canaccord views as compelling.
The acquisition includes the Vares Silver Project in Bosnia, with the deal expected to complete in the December quarter following shareholder approval in the September quarter, explain the analysts.
Canaccord retains a Hold rating and a $5.50 price target.
This report was published on June 13, 2025.
Target price is $5.50 Current Price is $5.00 Difference: $0.5
If ADT meets the Canaccord Genuity target it will return approximately 10% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 26.22 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.07.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 53.98 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.26.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ASX ASX LIMITED
Wealth Management & Investments - Overnight Price: $72.46
Jarden rates ((ASX)) as Neutral (3) -
Jarden notes ASX's five-year strategic plan centred on technology updates and cost profile, and the higher D&A expenses in the medium term imply pressure on EBIT margins.
The FY25 cost growth is expected to be within the 6-9% guidance range, but the FY26 guidance was above the consensus estimate.
On the positive side, the company said its new pricing policy allows it to target the historical return of 11.5% on capital by adjusting fees charged to customers.
The broker incorporated updated cost assumptions and revenue drivers, resulting in a 2.9% lift to FY25 EPS and a 1.1% rise to FY26.
Neutral. Target rises to $68.25 from $62.55.
This report was published on June 12, 2025.
Target price is $68.25 Current Price is $72.46 Difference: minus $4.21 (current price is over target).
If ASX meets the Jarden target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $66.20, suggesting downside of -9.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 223.30 cents and EPS of 262.90 cents.
At the last closing share price the estimated dividend yield is 3.08%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 263.8, implying annual growth of 7.7%.
Current consensus DPS estimate is 223.2, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 27.6.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 227.70 cents and EPS of 267.90 cents.
At the last closing share price the estimated dividend yield is 3.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 268.5, implying annual growth of 1.8%.
Current consensus DPS estimate is 225.4, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 27.1.
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AV1 ADVERITAS LIMITED
Overnight Price: $0.10
Taylor Collison rates ((AV1)) as Initiation of coverage with Speculative Buy (1) -
Back on June 6, Taylor Collison initiated coverage on Adveritas, highlighting its TrafficGuard (SaaS) platform as a proactive solution to digital advertising fraud (invalid traffic and advertising). The analyst began with a Speculative Buy rating and 17c target.
The platform provides real-time protection across Google Ads, mobile, affiliate, and social channels, helping marketers eliminate waste and optimise acquisition efficiency, explains the analyst.
The broker sees a strong commercial inflection point, with multi-year SaaS contracts, rising annual contract value, and agency distribution underpinning 61% year-on-year annual recurring revenue (ARR) growth.
Management recently secured its first $1m annual contract value (ACV) deal and first agency contract, validating its value proposition, according to the broker.
It's also thought the deal helps open scalable enterprise access across sectors like ecommerce and legal.
This report was published on June 6, 2025.
Target price is $0.17 Current Price is $0.10 Difference: $0.065
If AV1 meets the Taylor Collison target it will return approximately 62% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY25:
Taylor Collison forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.90 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 11.67.
Forecast for FY26:
Taylor Collison forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 52.50.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE